BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8756739)

  • 61. Heparin neutralizes serum antiplasmin inhibition of peripheral blood leukocyte fibrinolytic activity.
    Ghezzo F; Romano S; Mazzone R; Gorzegno G; Emanuelli G
    Thromb Res; 1987 Apr; 46(2):199-204. PubMed ID: 3603421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impaired fibrinolysis after kidney transplantation.
    Seitz R; Michalik R; Egbring R; Karges HE; Lange H
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():941-4. PubMed ID: 3887389
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease.
    Yamagishi K; Aleksic N; Hannan PJ; Folsom AR;
    J Atheroscler Thromb; 2010 Apr; 17(4):402-9. PubMed ID: 20379055
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Serum plasminogen and alpha-2-antiplasmin levels in chronic bronchopneumopathology with respiratory insufficiency].
    Lombardo G; Purello D'Ambrosio F; Lenzo G; Trimarchi S; Niosi G; Tigano F
    Riv Eur Sci Med Farmacol; 1988 Dec; 10(6):493-7. PubMed ID: 3274732
    [No Abstract]   [Full Text] [Related]  

  • 65. Fibrinolysis: molecular mechanism and pathophysiological aspects.
    Lijnen HR
    Sangre (Barc); 1984; 29(4-C):755-61. PubMed ID: 6240123
    [No Abstract]   [Full Text] [Related]  

  • 66. Fibrinolytic activity of oral cyclandelate in patients with generalized atherosclerotic vasculopathy: a double-blind study.
    Forconi S; Cappelli R; Guerrini M; Frigerio C; Messa GL; Furesi L
    J Int Med Res; 1990; 18(4):257-65. PubMed ID: 2121564
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Histochemical findings of fibrinolytic activities in the prostatic gland.
    Sugiura H; Shimaya M
    Invest Urol; 1970 Sep; 8(2):188-94. PubMed ID: 4099868
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical evaluation of measurement of plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen in various liver disease].
    Yanagisawa N; Sugaya H; Hisauchi T; Harada T
    Nihon Shokakibyo Gakkai Zasshi; 1988 Dec; 85(12):2601-9. PubMed ID: 3244179
    [No Abstract]   [Full Text] [Related]  

  • 69. Two forms of alpha 2-antiplasmin: post-traumatic changes in the rat.
    Högstorp H; Carlin G
    Ups J Med Sci; 1987; 92(1):79-83. PubMed ID: 2438835
    [TBL] [Abstract][Full Text] [Related]  

  • 70. On the role of the carbohydrate side chains of human plasminogen in its interaction with alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1981 Nov; 120(1):149-54. PubMed ID: 7308211
    [No Abstract]   [Full Text] [Related]  

  • 71. Plasminogen abnormalities in patients with Argentine hemorrhagic fever.
    Molinas FC; Kordich L; Porterie P; Lerer G; Maiztegui JI
    Thromb Res; 1987 Dec; 48(6):713-20. PubMed ID: 2448897
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [A congenital α2-antiplasmin deficiency].
    Igala M; Oukkach B; Khoubila N; Faez S; Benchekroun S
    Ann Biol Clin (Paris); 2013; 71(1):93-5. PubMed ID: 23396430
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mini-plasminogen like molecule in septic patients.
    Kordich LC; Porterie VP; Lago O; Bergonzelli GE; Sassetti B; Sanchez Avalos JC
    Thromb Res; 1987 Sep; 47(5):553-60. PubMed ID: 2445046
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies on a form of alpha 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen.
    Wiman B; Nilsson T; Cedergren B
    Thromb Res; 1982 Oct; 28(2):193-9. PubMed ID: 6817454
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic abnormalities of the fibrinolytic system.
    Aoki N
    Prog Clin Biol Res; 1981; 72():229-47. PubMed ID: 7199719
    [No Abstract]   [Full Text] [Related]  

  • 76. Two forms of alpha 2-antiplasmin: differences in KAV and isoelectric point.
    Högstorp H; Jacobsson H; Wallin R; Saldeen T
    Thromb Res; 1984 Sep; 35(5):559-65. PubMed ID: 6484898
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protease inhibitors of human plasma. Alpha-2-antiplasmin.
    Lijnen HR; Collen D
    J Med; 1985; 16(1-3):225-84. PubMed ID: 2430039
    [No Abstract]   [Full Text] [Related]  

  • 78. Urokinase activity and fibrinolysis in renal diseases.
    Nowak A; Zahorska-Markiewicz B
    Pol Med J; 1966; 5(2):292-7. PubMed ID: 5915715
    [No Abstract]   [Full Text] [Related]  

  • 79. The kidneys and the fibrinolytic activity in the blood.
    Isacson S; Nilsson IM
    Thromb Diath Haemorrh; 1969 Nov; 22(2):211-5. PubMed ID: 5380944
    [No Abstract]   [Full Text] [Related]  

  • 80. [Fibrinolysis as a diagnostic test for prostatic carcinoma].
    Burchardt P; Marscek M
    Urologe; 1971 Nov; 10(6):300-2. PubMed ID: 5137517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.